Parent Company Brand identity. This Pharmaceutical Company is primarily launching a new product treating the symptoms of Nocturia,
Update: 2017 The world’s leading authority on nocturia, Dr. Jeffrey Weiss, reviewed the results of our recently concluded Phase 2 clinical trial. He wrote, “The study is stunning. Congratulations. It is a monumental achievement.” Last month he submitted his own abstract as an application to present the trial results at the annual meeting of the American Urological Association.
FDA Approved Double-Blinded Phase 2 Trial Completed
Investor Presentation. We developed the talking points, content and sequence as well as the deck for this $3.5M funding round.
The product helps people to get a good night's sleep... so the tagline is "Zzzzzzzzzzz Finally a Solution to Nocturia"
